Welcome to our dedicated page for Mycronic news (Ticker: MICLF), a resource for investors and traders seeking the latest updates and insights on Mycronic stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mycronic's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mycronic's position in the market.
Mycronic AB has secured an order worth USD 52-60 million from a current customer in Asia for five systems, including three Prexision 8 Evo and one Prexision 8 Entry Evo. Deliveries are scheduled between Q2 2024 and Q1 2025. The Prexision 8 Entry Evo is the latest model, allowing customers to upgrade for producing advanced photomasks. This order highlights Mycronic's replacement program and continued demand for its innovative technology, with a noted second order for the Entry Evo model.
Mycronic AB reported its first quarter 2021 results showing mixed performance. Order intake decreased by 28% to SEK 1,027 million, while net sales surged by 75% to SEK 1,291 million, a notable increase attributed to strong growth in the High Volume and Pattern Generator divisions. EBIT rose to SEK 498 million with an improved margin of 39%. The board forecasts consolidated net sales of SEK 3.9 billion for 2021. CEO Anders Lindqvist expressed confidence in the company's resilience and growth prospects.
FAQ
What is the market cap of Mycronic (MICLF)?
